Literature DB >> 11983257

Muscle specific versus ubiquitous expression of Gag based HIV-1 DNA vaccines: a comparative analysis.

Alexandra Bojak1, Diana Hammer, Hans Wolf, Ralf Wagner.   

Abstract

Most studies on DNA-based immunization have used viral promoters to drive antigen expression. In this study, we analyzed the properties of the commonly used CMV promoter, the tissue specific murine muscle creatine kinase (MCK) promoter as well as a hybrid MCK/CMV promoter regarding promoter activity and tissue specificity in vitro. Furthermore, the efficiency of inducing HIV-1 Gag specific immune responses in vivo following intramuscular immunization of naked DNA containing a codon optimized synthetic gene was compared. Although antibody titers and cellular immune responses using the MCK construct were slightly reduced as compared to conventional CMV based vector modules, the utilization of nonviral promoters may add significantly to the safety of future DNA vaccines.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11983257     DOI: 10.1016/s0264-410x(02)00081-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery.

Authors:  Chunping Qiao; Chi-Hsien Wang; Chunxia Zhao; Peijuan Lu; Hiroyuki Awano; Bin Xiao; Jianbin Li; Zhenhua Yuan; Yi Dai; Carrie Bette Martin; Juan Li; Qilong Lu; Xiao Xiao
Journal:  Mol Ther       Date:  2014-07-22       Impact factor: 11.454

Review 2.  DNA vaccines: ready for prime time?

Authors:  Michele A Kutzler; David B Weiner
Journal:  Nat Rev Genet       Date:  2008-10       Impact factor: 53.242

3.  Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.

Authors:  Wing-Pui Kong; Yue Huang; Zhi-Yong Yang; Bimal K Chakrabarti; Zoe Moodie; Gary J Nabel
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

4.  The Cellular Processing Capacity Limits the Amounts of Chimeric U7 snRNA Available for Antisense Delivery.

Authors:  Agathe Eckenfelder; Julie Tordo; Arran Babbs; Kay E Davies; Aurélie Goyenvalle; Olivier Danos
Journal:  Mol Ther Nucleic Acids       Date:  2012-06-26       Impact factor: 10.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.